These results demonstrate that FA-PEG10k-S-Hu5 has the potential to achieve targeted accumulation in tumor tissues via folate-FRα binding by leveraging the differential expression of FR between tumor and normal tissues, and upon exposure to the tumor microenvironment, the shielding is removed to restore the antibody’s CD47-binding activity. The gene discussed is CD47; the disease is neoplasm.